|
|
|
|
|
|
|
|
Cancer Network
..... These results raise two questions, Kang wrote: whether the CHORUS findings apply to expert surgeons, and which patients would benefit most from this treatment strategy.
“Concerns are also increasing that neoadjuvant chemotherapy could be used as an excuse for neglecting maximum surgical efforts or improvement of competent surgical skills,” Kang wrote. “Despite these questions and concerns, Kehoe and colleagues are to be congratulated on their research showing that neoadjuvant chemotherapy lowers treatment-related morbidity without sacrificing treatment efficacy. However, efforts should now be directed towards identifying and resolving the remaining uncertainties.”
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.